TGEN (Tecogen) Accounts Receivable : $5.45 Mil (As of Sep. 2024)

View and export this data going back to 2014. Start your Free Trial

What is Tecogen Accounts Receivable?

Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Tecogen's accounts receivables for the quarter that ended in Sep. 2024 was $5.45 Mil.

Accounts receivable can be measured by Days Sales Outstanding. Tecogen's Days Sales Outstanding for the quarter that ended in Sep. 2024 was 88.30.

In Ben Graham's calculation of Net-Net Working Capital, accounts receivable are only considered to be worth 75% of book value. Tecogen's Net-Net Working Capital per share for the quarter that ended in Sep. 2024 was $-0.24.

Tecogen Accounts Receivable Historical Data

The historical data trend for Tecogen's Accounts Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tecogen Accounts Receivable Chart

Tecogen Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Receivable

Get a 7-Day Free Trial

14.57

8.67

8.48

6.71

6.74

Tecogen Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Accounts Receivable	Get a 7-Day Free Trial															7.70	6.74	6.53	5.36	5.45

Tecogen Accounts Receivable Calculation

Accounts Receivable is money owed to a business by customers and shown on its Balance Sheet as an asset.

Tecogen Accounts Receivable Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's accounts receivables are being managed.

Tecogen's Days Sales Outstanding for the quarter that ended in Sep. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	5.448	/	5.63	*	91
=	88.30

2. In Ben Graham's calculation of Net-Net Working Capital (NNWC), Tecogen's accounts receivable are only considered to be worth 75% of book value:

Tecogen's Net-Net Working Capital Per Share for the quarter that ended in Sep. 2024 is calculated as:

	Net-Net Working Capital Per Share
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1.282	+	0.75 * 5.448	+	0.5 * 9.895	-	16.287
-	0	-	-0.111)	/	24.8503
=	-0.24

Be Aware

Net receivables tells us a great deal about the different competitors in the same industry. In competitive industries, some attempt to gain advantage by offering better credit terms, causing increase in sales and receivables.

If company consistently shows lower % Net receivables to gross sales than competitors, then it usually has some kind of competitive advantage which requires further digging.

Average Days Sales Outstanding is a good indicator for measuring a company's sales channel and customers. A company may book great revenue and earnings growth but never receive payment from their customers. This may force a write-off in the future and depress future earnings.

Tecogen Accounts Receivable Related Terms

Thank you for viewing the detailed overview of Tecogen's Accounts Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.

Tecogen Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Tecogen Inc (OTCPK:TGEN) » Definitions » Accounts Receivable

Comparable Companies

Traded in Other Exchanges

2T1:Germany

Address

45 First Avenue, Waltham, MA, USA, 02451

Website

https://www.tecogen.com

Tecogen Inc, designs, manufactures, markets, and maintains high-efficiency, ultra-clean cogeneration products. It operates in three business segments, namely Products, Services, and Energy Production. Products segment designs, manufactures, and sells industrial and commercial cogeneration systems. The services segment provides operations and maintenance services and turn-key installation for products under long-term service contracts. The Energy Production segment sells energy in the form of electricity, heat, hot water, and cooling to the customers under long-term energy sales agreements.

Executives

Earl R Lewis	director	C/O NXSTAGE MEDICAL INC. (NXTM), 439 SOUTH UNION STREET, 5TH FLOOR, LAWRENCE MA 01843
John Hatsopoulos	director, 10 percent owner, officer: Chief Executive Officer	85 FIRST AVENUE, WALTHAM MA 02451
Susan B Hirsch	director	280 OLD SOMERSET ROAD, WATCHUNG NJ 07069
Abinand Rangesh	director, officer: Chief Financial Officer	45 FIRST AVE, WALTHAM MA 02451
John M Albertine	director	100 FEDERAL DRIVE, FREDERICKSBURG VA 22405
Pacheco Ann Marie Brown	10 percent owner, other: Trustee	C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
Ralph Jenkins	director	45 FIRST AVE, WALTHAM MA 02451
Fred Holubow	director
Locke M. Benjamin	officer: Co-CEO	45 FIRST AVE, WALTHAM MA 02451
Whiting John Kimball Iv	officer: General Counsel & Secretary	49 L STREET, UNIT 9, BOSTON MA 02127
Deanna M Petersen	director	45 FIRST AVENUE, WALTHAM MA 02451
Yiannis Monovoukas	10 percent owner	TEI BIOSCIENCES, INC., 7 ELKINS STREET, BOSTON MA 02127
Charlest Maxwell	director	6100 NORTH WESTERN AVE, OKLAHOMA CITY OK 73118
Keith Davidson	director	C/O TECOGEN INC., 45 FIRST AVE., WALTHAM MA 02451
David A Garrison	officer: CFO, Treasurer and Secretary	C/O ARRHYTHMIA RESEARCH TECHNOLOGY INC., 25 SAWYER PASSWAY, FITCHBURG MA 01420